Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Fatigue 9Glioma 3Sleep Initiation and Maintenance Disorders 2Neoplasms 2Central Nervous System Neoplasms 2cyclopia sequence 1Unspecified Adult Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1Ependymoma 1Cognition Disorders 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Modafinil × Clear all
NCT00825227 2017-11-17

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
10 enrolled 7 charts

Fatigue, Neoplasms

NCT00178373 2015-12-23

Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

University of Rochester

Phase 2 Completed
96 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡